Børge Sørvoll
Vermogen: 244 676 $ op 31-05-2026
Vermogen: 244 676 $ op 31-05-2026
Børge Sørvoll currently works at Biotec BetaGlucans AS, as Chairman and ArcticZymes Technologies ASA, as Chief Financial Officer from 2014.
Mr. Sørvoll also formerly worked at Troms Kraft Invest AS, as Managing Director & Chief Financial Officer, Front Exploration AS, as Chief Financial Officer, and Subsea 7 Norway AS, as Manager.
Mr. Sørvoll received his undergraduate degree from the University of Wyoming.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2024 | 100.428 ( 0,2% ) | 244 676 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Financieel Directeur/CFO | 01-10-2014 |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Develops and manufactures immune modulating compounds for the human health sectors | Voorzitter | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Front Exploration AS
Front Exploration AS Contract DrillingIndustrial Services Explores oil and gas | Financieel Directeur/CFO | - |
Subsea 7 Norway AS
Subsea 7 Norway AS Miscellaneous Commercial ServicesCommercial Services Engages in general trading activities | Corporate Officer/Principal | - |
Troms Kraft Invest AS | Algemeen Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
University of Wyoming
University of Wyoming Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ArcticZymes Technologies ASA
ArcticZymes Technologies ASA Medical SpecialtiesHealth Technology Develops and manufactures immune modulating compounds | Health Technology |
Front Exploration AS
Front Exploration AS Contract DrillingIndustrial Services Explores oil and gas | Industrial Services |
Subsea 7 Norway AS
Subsea 7 Norway AS Miscellaneous Commercial ServicesCommercial Services Engages in general trading activities | Commercial Services |
Troms Kraft Invest AS | |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Develops and manufactures immune modulating compounds for the human health sectors | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau